Global Liposome Drug Delivery Market Study 2016-2026, by Segment (Liposomal Doxorubicin, Liposomal Amphoteracin B, … …), by Market (Fungal Infection Therapy, Cancer & Tumor Therapy, … …), by Company (Johnson & Johnson, Gilead Sciences, … …)

  • Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. 

    The global Liposome Drug Delivery market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

    Liposomal Doxorubicin

    Liposomal Amphoteracin B

    Liposomal Paclitaxel

    Liposomal Bupivacaine

    Other Liposomals

    Demand Coverage (Market Size & Forecast, Consumer Distribution):

    Fungal Infection Therapy

    Cancer & Tumor Therapy

    Others

    Company Coverage (Sales data, Main Products & Services etc.):

    Johnson & Johnson

    Gilead Sciences

    Pacira

    Sun Pharmaceutical

    Luye Pharma

    Sigma-Tau Group

    Teva Pharmaceutical

    Ipsen (Onivyde)

    Fudan-Zhangjiang

    CSPC

    Novartis

    Kingond Pharm

    Shanghai New Asia

    Spectrum Pharmaceuticals

    Major Region Market

    North America

    Europe

    Asia-Pacific

    South America

    Middle East & Africa

     

  • Table of Content

    1 Industry Overview

    1.1 Liposome Drug Delivery Industry

    1.1.1 Overview

    1.1.2 Products of Major Companies

    1.2 Market Segment

    1.2.1 Industry Chain

    1.2.2 Consumer Distribution

    1.3 Price & Cost Overview

    2 Liposome Drug Delivery Market by Type

    2.1 By Type

    2.1.1 Liposomal Doxorubicin

    2.1.2 Liposomal Amphoteracin B

    2.1.3 Liposomal Paclitaxel

    2.1.4 Liposomal Bupivacaine

    2.1.5 Other Liposomals

    2.2 Market Size by Type

    2.3 Market Forecast by Type

    3 Global Market Demand

    3.1 Segment Overview

    3.1.1 Fungal Infection Therapy

    3.1.2 Cancer & Tumor Therapy

    3.1.3 Others

    3.2 Market Size by Demand

    3.3 Market Forecast by Demand

    4 Major Region Market

    4.1 Global Market Overview

    4.1.1 Market Size & Growth

    4.1.2 Market Forecast

    4.2 Major Region

    4.2.1 Market Size & Growth

    4.2.2 Market Forecast

    5 Major Companies List

    5.1 Johnson & Johnson (Company Profile, Sales Data etc.)

    5.2 Gilead Sciences (Company Profile, Sales Data etc.)

    5.3 Pacira (Company Profile, Sales Data etc.)

    5.4 Sun Pharmaceutical (Company Profile, Sales Data etc.)

    5.5 Luye Pharma (Company Profile, Sales Data etc.)

    5.6 Sigma-Tau Group (Company Profile, Sales Data etc.)

    5.7 Teva Pharmaceutical (Company Profile, Sales Data etc.)

    5.8 Ipsen (Onivyde) (Company Profile, Sales Data etc.)

    5.9 Fudan-Zhangjiang (Company Profile, Sales Data etc.)

    5.10 CSPC (Company Profile, Sales Data etc.)

    5.11 Novartis (Company Profile, Sales Data etc.)

    5.12 Kingond Pharm (Company Profile, Sales Data etc.)

    5.13 Shanghai New Asia (Company Profile, Sales Data etc.)

    5.14 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)

    6 Conclusion

     

This is a single user license, allowing one specific user access to the product.

This is an enterprise license, allowing all employees within your organisation access to the product.

Need Assistance ?

Our Clients